HALOZYME THERAPEUTICS, INC. (HALO) research
HALOZYME THERAPEUTICS, INC.- Sector
- Biotechnology
- Last price
- $112.45
- As of
HALOZYME THERAPEUTICS, INC. (HALO): 7 institutional managers tracked by Kresmion reported non-option positions in their 2026Q2 Form 13F filings, and the most recent SEC filing on record for the company is a Form 8-K filed 2026-09-18.
As of . Source: SEC EDGAR filings for HALO. Method and limitations.
Share the HALO intelligence card
See HALO live in the terminal
Track HALO's insider trades, 13F flows, options positioning, and cross asset confluence as they update, on one live board. Free account.
Open the live HALO terminal, freeActive signals for HALO
- highCONSENSUS_BUY
3 tracked funds increased HALO this 2026Q2, institutional consensus
- highINSTITUTIONAL_EXIT
MILLENNIUM MANAGEMENT LLC cut 96% of HALO (2026Q2)
- highINSTITUTIONAL_SURGE
CITADEL ADVISORS LLC added +1685% to HALO (2026Q2)
- highINSTITUTIONAL_EXIT
CITADEL ADVISORS LLC cut 72% of HALO (2026Q2)
- highINSTITUTIONAL_SURGE
CITADEL ADVISORS LLC added +179% to HALO (2026Q2)
FREE, NO ACCOUNT
Every signal on HALO, as it fires
You are seeing 5 of 36 signals recorded on HALO since 2026-05-17.
The five above landed across 2 days. The other 31 were recorded on 5 other days. 31 of the 36 are institutional flow rows, which arrive in batches on filing days.
No fixed schedule: it goes out when the data has something in it. Unsubscribe anytime. We never sell your data.
Largest reported share positions in HALO (2026Q2)
| Manager / security | Market value | % portfolio | QoQ |
|---|---|---|---|
| D. E. Shaw & Co., Inc.CUSIP 40637H109 · 2026Q2 | $157M | 0.07% | , |
| TWO SIGMA INVESTMENTS, LPCUSIP 40637H109 · 2026Q2 | $129.4M | 0.09% | , |
| CITADEL ADVISORS LLCCUSIP 40637HAF6 · 2026Q2 | $96.7M | 0.01% | , |
| Point72 Asset Management, L.P.CUSIP 40637HAF6 · 2026Q2 | $60.5M | 0.07% | , |
| RENAISSANCE TECHNOLOGIES LLCCUSIP 40637H109 · 2026Q2 | $37.5M | 0.05% | , |
| Bridgewater Associates, LPCUSIP 40637H109 · 2026Q2 | $36.3M | 0.15% | , |
| MILLENNIUM MANAGEMENT LLCCUSIP 40637HAF6 · 2026Q2 | $27.5M | 0.01% | , |
| CITADEL ADVISORS LLCCUSIP 40637H109 · 2026Q2 | $22.6M | 0.00% | , |
| CITADEL ADVISORS LLCCUSIP 40637HAD1 · 2026Q2 | $13.3M | 0.00% | , |
| Point72 Asset Management, L.P.CUSIP 40637HAD1 · 2026Q2 | $8.4M | 0.01% | , |
| MILLENNIUM MANAGEMENT LLCCUSIP 40637H109 · 2026Q2 | $1.6M | 0.00% | , |
Quarterly SEC Form 13F disclosures from the managers Kresmion tracks, not a complete ownership ranking. Non-option holdings only; reported put and call positions are excluded. Different securities are labeled by CUSIP. Values are reporting-period snapshots, not current position values. Filings can arrive up to 45 days after quarter-end.
Recent SEC filings, HALO
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 10-QSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 10-QSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
Related tickers
See more HALO signals as they fire
Kresmion publishes filings, 13F flows, on-chain whale activity, and cross-asset signals in real time. Open a live board scoped to HALOand get the insider, 13F, options, and confluence read in one view.